3/13/2014 6:59:03 AM
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today announced the addition of Nancy J. Wysenski to the company’s Board of Directors. Ms. Wysenski has more than 35 years’ experience in the life science industry, the majority of which have been spent in commercial leadership roles.
Help employers find you! Check out all the jobs and post your
comments powered by